Cite
HARVARD Citation
Komrokji, R. et al. (n.d.). Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes. American journal of hematology. 89 (8), pp. 809-812. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Komrokji, R. et al. (n.d.). Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes. American journal of hematology. 89 (8), pp. 809-812. [Online].